Expertise in
12
conditions

Jens T. Siveke

Bridge Institute Of Experimental Tumor Therapy And Division Of Solid Tumor Translational Oncology, 
Essen, NW, DE 
Expertise in
12
conditions
Bridge Institute Of Experimental Tumor Therapy And Division Of Solid Tumor Translational Oncology, 
Essen, NW, DE 

Overview

Jens Siveke practices practicing medicine in Essen, Germany.

Mr. Siveke is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Solitary Fibrous Tumor, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

He is actively involved in clinical research, co-authoring 253 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Bridge Institute Of Experimental Tumor Therapy And Division Of Solid Tumor Translational Oncology, Essen, NW, Germany
Other Locations
Heidelberg, BW, Germany
Munich, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma
A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma
Enrollment Status: Completed
Publish Date: March 17, 2026
Intervention Type: Biological, Drug
Study Drugs: IMCgp100, Dacarbazine, Ipilimumab, Pembrolizumab
Study Phase: Phase 2
A Phase Ib/II Single-arm Study Evaluating the Safety and Efficacy of Combined Immunotherapy With mFOLFOX6, Bevacizumab and Atezolizumab in Advanced-stage Biliary Tract Cancer
A Phase Ib/II Single-arm Study Evaluating the Safety and Efficacy of Combined Immunotherapy With mFOLFOX6, Bevacizumab and Atezolizumab in Advanced-stage Biliary Tract Cancer
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-
Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-
Enrollment Status: Completed
Publish Date: September 20, 2019
Intervention Type: Dietary supplement
Study Phase: Phase 2
View 2 Less Clinical Trials

253 Total Publications

Early recurrence prediction after curative-intent surgery of intrahepatic cholangiocarcinoma using a novel weighted tumor burden score.
Early recurrence prediction after curative-intent surgery of intrahepatic cholangiocarcinoma using a novel weighted tumor burden score.
Journal: World journal of surgical oncology
Published: June 03, 2026

Frequently Asked Questions about Jens T. Siveke

Is Jens T. Siveke a top-rated expert for Pancreatic Ductal Adenocarcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Jens T. Siveke is classified as an Elite expert for Pancreatic Ductal Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jens T. Siveke participate in research or clinical trials?

Yes. Jens T. Siveke has published 253 articles and abstracts on conditions like Pancreatic Ductal Adenocarcinoma. You can view a list of Jens T. Siveke's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Siveke's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile